Basic science researcher blends academic, industry experience to lead Alzheimer's drug discovery efforts
Timothy Richardson is a research professor of medicine at the IU School of Medicine and helps lead the TREAT-AD drug discovery center.
Research space utilization highlight: Q&A with John Leck
John Leck is the director of space planning and utilization at the IU School of Medicine. He discusses his new role, background, and the importance
IU medical scientists, Purdue engineers meet at symposium to foster collaborative research
Scientists, physicians and engineers representing gathered to share groundbreaking work, raise important questions and plant the seeds of future research collaboration and innovation.
IU neurologist's research leads to first FDA-approved drug to treat neurofibromatosis type 1
Patients who participated in the clinical trial of the new therapy not only experienced reduction in NF1 and plexiform neurofibromas tumor volume, but also reported
IMPD program combines research and compassion to support non-fatal shooting survivors
Research led by Lauren Magee is enhancing support for gun violence survivors and generating data that contributes to safer community outcomes through the IMPD’s Non-Fatal
IU Ehlers-Danlos Syndrome expert educates health care providers throughout the world
Clair Francomano, MD, is one of the world’s foremost experts in Ehlers-Danlos syndromes and hypermobility spectrum disorders. She educates health care professionals and people worldwide
Researchers investigating how gut bacteria impacts Alzheimer’s disease progression
A team of researchers at the Indiana University School of Medicine is investigating a bacterial connection between the gut microbiome and microglia actions in Alzheimer’s
Study investigating why people who sustain traumatic brain injuries have a higher chance of developing Alzheimer’s disease
Researchers from the Indiana University School of Medicine are investigating why individuals who have experienced traumatic brain injuries — whether from a single or repeated
Clinical trials in ALS help researchers test potential therapies, track disease course while aiming for a cure
Also known as Lou Gehrig's disease, ALS is a rare, terminal neurodegenerative disease that weakens muscles throughout the body. It can occur in anyone, anywhere,
IU researcher seeks to solve 'black box' nature of AI, presents groundbreaking research at Spring ADRC
IU School of Medicine's Selena Wang is trying find the answer to many complexities of the brain and Alzheimer's disease using artificial intelligence.